We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current SKYE market cap is 88.13M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 4.55M |
| Operating Income | -24.71M | -4.09M | -6.15M | -8.41M | -4.97M |
| Net Income | -24.95M | -4.42M | -5.02M | -7.9M | -3.9M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 152k |
| Operating Income | -6.63M | -6.29M | -7.85M | -18.31M | -34.74M |
| Net Income | 1.05M | -6.56M | -8.52M | -19.48M | -37.65M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 15.6M | 11.94M | 94.84M | 87.26M | 81.54M |
| Total Liabilities | 13.91M | 14.07M | 15.95M | 14.45M | 5.73M |
| Total Equity | 1.7M | -2.13M | 78.88M | 72.81M | 75.8M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2M | 2.67M | 9.86M | 9.11M | 11.94M |
| Total Liabilities | 1.45M | 2.22M | 3.99M | 12.12M | 14.07M |
| Total Equity | 548k | 451k | 5.86M | -3.01M | -2.13M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.11M | -13.95M | -4.71M | -11.8M | -17.06M |
| Investing | 6.6M | 6.6M | 1.14M | 1.11M | -336k |
| Financing | 16.47M | 16.44M | 85.65M | 83.56M | 83.56M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.03M | -6.06M | -6.47M | -12.74M | -13.95M |
| Investing | N/A | -7k | -91k | 5.21M | 6.6M |
| Financing | 6.01M | 6.7M | 13.08M | -209k | 16.44M |
| Market Cap | 88.13M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 30.34M |
| Average Volume (1 week) | 362.82k |
| Average Volume (1 Month) | 167.45k |
| 52 Week Change | -78.48% |
| 52 Week High | 17.6473 |
| 52 Week Low | 2.31 |
| Spread (Intraday) | 0.08 (2.62%) |
| Company Name | Skye Bioscience Inc |
| Address |
701 s carson st carson city, nevada 89701 |
| Website | https://skyebioscience.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
